Benzoic Acids

<p>3,5-Dimethylanthranilic acid is an acridone that has significant effects on the topoisomerase enzymes. It is a reactive compound and can cause sensitivity to light and heat, as well as irritation in the respiratory tract. 3,5-Dimethylanthranilic acid has been shown to have antitumour activity in mice. 3,5-Dimethylanthranilic acid also has cytotoxic potency against cancer cells and can be used to evaluate the sensitivity of tumours to anticancer drugs. This compound may also have mutagenic properties. The dehalogenation of 3,5-dimethylanthranilic acid is not yet fully understood.</p>

<p>3-Mercaptobenzoic acid is an antimicrobial agent that inhibits bacterial enzyme. It binds to the active site of the enzyme, and prevents it from carrying out its function. 3-Mercaptobenzoic acid has been shown to be an efficient method for the prevention of corrosion in metal surfaces. The binding of 3-mercaptobenzoic acid to metal ions forms a protective film on the surface, preventing corrosion.</p>

<p>2-Amino-5-(trifluoromethyl)benzoic acid methyl ester is a fine chemical that can be used in research and development. It is an intermediate for the synthesis of other compounds, such as pharmaceuticals and pesticides. This compound has a wide range of uses in various chemical reactions, including as a building block or reaction component.</p>

<p>4-Bromo-3-chlorobenzoic acid is a molecule that belongs to the class of antimicrobial compounds and is used for the treatment of gram-negative pathogens. It inhibits the growth of these bacteria by blocking their ability to synthesize DNA, RNA, and proteins. 4-Bromo-3-chlorobenzoic acid has been shown to be effective against bacteria in mammalian cells and also has activity against multidrug resistant strains. This compound is biosynthesized in plant cells from carbon sources like glucose, and it can be found in plants like carrot tissue. The resistance of bacteria to this compound has been observed globally, with outbreaks occurring in Japan and India.</p>

<p>2-(Bromomethyl)-3-nitrobenzoic acid methyl ester is a synthetic compound that is a byproduct of ammonium nitrate production. It is prepared by the reaction of 2-methyl-3-nitrobenzoic acid with bromine and methanol in the presence of palladium catalyst. The product is used to synthesize l-glutamic acid, which has many applications in industry.</p>

<p>Building block in tetracycline antibiotic synthesis</p>

<p>3,5-Dimethoxy-4-hydroxybenzoic acid methyl ester (DMHBME) is a natural compound that has been shown to have high redox potential values and chemical stability. This compound is an inhibitor of p-hydroxylases and has been shown to inhibit human serum laccase activity. DMHBME also inhibits polymerase chain reactions in the presence of DNA templates, which may be due to its ability to bind to the enzyme at the active site. DMHBME is a potent antimicrobial agent that can be used as a fungicide or preservative in food products. It is also effective against bacteria such as Staphylococcus aureus, Clostridium perfringens, Escherichia coli, and Mycobacterium tuberculosis.</p>

<p>3-Bromo-5-cyanobenzoic acid is a fine chemical that is used as a reagent or intermediate in the production of other chemicals. 3-Bromo-5-cyanobenzoic acid can be used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and perfumes. This compound is also useful as a building block for making speciality chemicals and research chemicals. 3-Bromo-5-cyanobenzoic acid is versatile because it can be used in many different reactions with many different substrates to make many different products.</p>

<p>2-Amino-3-fluorobenzoic acid methyl ester (2AFBME) is an antibacterial agent that inhibits bacterial protein synthesis by binding to ribosomes and inhibiting the release of amino acids during translation. 2AFBME has been shown to have antibacterial activity against aureus, streptococcus, and staphylococcus strains in laboratory tests. The clinical development of 2AFBME has not yet been completed.</p>

<p>3-Bromo-4-nitrobenzoic acid is a chemical compound with the molecular formula CHBrNO2. It is a versatile building block that can be used in the synthesis of many different compounds. 3-Bromo-4-nitrobenzoic acid is a white crystalline solid that is soluble in water, ethanol, and ether. It reacts with many substances to produce other useful compounds. It can also be used as a reagent for the detection of proteins or nucleic acids. This product has been shown to be an effective intermediate in organic reactions and has been used as a scaffold in the synthesis of complex molecules such as natural products, pharmaceuticals, and agrochemicals.</p>

<p>3-Amino-5-bromobenzoic acid is a synthetic, water soluble anti-inflammatory agent. It is cytotoxic to macrophages in vitro and has significant efficacy in vivo. Its mechanism of action is to inhibit the synthesis of nucleotides in the cell. 3-Amino-5-bromobenzoic acid also inhibits inflammation by inhibiting prostaglandin synthesis and has been shown to be effective against seborrheic dermatitis. This drug has pharmacokinetic properties that are favourable for oral administration and is rapidly absorbed from the gastrointestinal tract with a half life of 2 hours. The drug is eliminated through the kidneys, with an elimination half life of 6 hours.</p>

<p>2-(4-Hydroxyphenylazo)benzoic acid is a molecule that is used in the production of human immunoglobulin. It is activated with fatty acids and oligosaccharides to form a complex, which can be detected using confocal microscopy. The matrix-assisted laser ablation technique was used to determine the chemical structures and hydrogen bonding interactions of this molecule. 2-(4-Hydroxyphenylazo)benzoic acid has been shown to inhibit microbial infections by binding to the sodium salt form of Streptavidin, which inhibits bacterial growth. This molecule also has been used as an indicator for trifluoroacetic acid, which can be used as a sample preparation reagent.</p>

<p>3,5-Dimethoxybenzoic acid ethyl ester is a carbonic acid ester that can be used as a synthetic intermediate. It is synthesized by reacting 3,5-dimethoxybenzoic acid with the ethyl chloride. The molecular weight of 3,5-dimethoxybenzoic acid ethyl ester is 222.6 g/mol. The homologous series includes dimethylformamide, diethylformamide, and diisopropylformamide. This compound has been shown to inhibit growth factor signaling in vitro and in vivo and may have potential therapeutic applications for cancer treatment. Impurities that may be found in 3,5-dimethoxybenzoic acid ethyl ester include chloride and sulfinyl groups. Synopses of the molecular modeling study are available on request.</p>

<p>3,5-Dichlorosalicylic acid is a proton donor that is used to inhibit the 5-nitrosalicylic acid chain reaction. It has a high binding constant with the chlorine atom and can be used as a competitive inhibitor for the binding of 5-nitrosalicylic acid to its target enzyme. 3,5-Dichlorosalicylic acid inhibits the polymerase chain reaction by binding to DNA. This chemical also has biological properties that are similar to those of salicylic acid, including anti-inflammatory activities. 3,5-Dichlorosalicylic acid is not an effective anti-cancer agent because it does not form intramolecular hydrogen bonds or hydrogen bond interactions with DNA bases.</p>

<p>2,5-Difluoro-4-methylbenzoic acid methyl ester is used as a reactive chemical in synthesis of pharmaceuticals and other chemicals. 2,5-Difluoro-4-methylbenzoic acid methyl ester reacts with amines to form the corresponding amides. It can also react with alcohols to form the corresponding ethers or it can be used as an intermediate for preparing other chemicals such as 4-(2,5-dichloro-4-methylphenyl)morpholine.</p>

<p>4-Bromo-2-nitrobenzoic acid is an anthranilic acid derivative that can be used as a radiolabel for the diagnosis of bladder cancer. The uptake of 4-Bromo-2-nitrobenzoic acid in the bladder is proportional to the number of cells, which are then detected by positron emission tomography (PET) scanning. The affinity of 4-Bromo-2-nitrobenzoic acid to human bladder tissue was determined by measuring its uptake in humans and rats. 4-Bromo-2-nitrobenzoic acid has been shown to be effective against cancer cells in vitro. Radiolabeling with this compound allows for more accurate diagnostic imaging than using other radiopharmaceuticals.</p>

<p>4-(Acetylamino)-2-nitrobenzoic acid (AAANB) is a versatile building block that can be used in the synthesis of a wide range of organic and pharmaceutical compounds. AAANB is an intermediate in the preparation of 4-Amino-3-nitrophenol, which is an important research chemical. This compound is a useful scaffold for the synthesis of organic compounds with various biological activities. The CAS number for this product is 21573-29-5.</p>

<p>2,6-Dibromobenzoic acid is a synthetic molecule that can be used to synthesize pyrrole derivatives in the presence of a base. It has been shown to react with a number of molecules, including halogens and chlorides. The active site of 2,6-dibromobenzoic acid is its bromine atom. The steric interactions between the 2,6-dibromobenzoic acid molecule and the substrate are strong enough to prevent other molecules from accessing the active site. Chlorides and diphenylmethane can also bind to 2,6-dibromobenzoic acid due to their similar properties. This molecule has also been shown to interact with aluminium and solvents such as ethanol or acetone.</p>

<p>Intermediate in the synthesis of idelalisib</p>

<p>2,4-Dihydroxybenzoic acid (2,4-DB) is a metabolite of salicylic acid. It is used as an intermediate in the production of various drugs and dyes. 2,4-DB has been shown to be effective against hepatic steatosis induced by hydrogen fluoride in mice. This drug also inhibits mitochondrial membrane potential and DNA binding activity in human serum. 2,4-DB can bind to the α subunit of mitochondrial ATPase and act as a competitive inhibitor for p-hydroxybenzoic acid which is essential for the activation of this enzyme. The x-ray diffraction data from crystalline 2,4-DB shows that this compound binds to dna with coordination geometry that resembles that of salicylic acid. The kinetic studies have shown that 2,4-DB reacts noncompetitively with nonsteroidal anti-inflammatory drugs (NSAIDs).</p>